Abstract
Pharmacoeconomic Assessment of Sucroferric Oxyhydroxide Vs Sevelamer Carbonate In Patients With Chronic Kidney Disease In Belgium and The Netherlands
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have